Foundry Partners’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-70,245
| Closed | -$972K | – | 296 |
|
|
2024
Q2 | $972K | Sell |
70,245
-207,926
| -75% | -$3.29M | 0.05% | 215 |
|
|
2024
Q1 | $5.21M | Buy |
278,171
+20,679
| +8% | +$414K | 0.28% | 122 |
|
|
2023
Q4 | $5.83M | Buy |
257,492
+13,082
| +5% | +$284K | 0.35% | 93 |
|
|
2023
Q3 | $6.06M | Sell |
244,410
-25,329
| -9% | -$637K | 0.38% | 81 |
|
|
2023
Q2 | $7.57M | Buy |
269,739
+145,764
| +118% | +$3.62M | 0.46% | 60 |
|
|
2023
Q1 | $2.77M | Buy |
123,975
+15,935
| +15% | +$417K | 0.17% | 179 |
|
|
2022
Q4 | $2.87M | Sell |
108,040
-80
| -0.1% | -$2.61K | 0.16% | 176 |
|
|
2022
Q3 | $3.07M | Buy |
108,120
+75,985
| +236% | +$1.95M | 0.19% | 151 |
|
|
2022
Q2 | $669K | Buy |
+32,135
| New | +$602K | 0.04% | 233 |
|
|
2019
Q2 | – | Sell |
-366,668
| Closed | -$2.58M | – | 391 |
|
|
2019
Q1 | $2.58M | Buy |
366,668
+21,031
| +6% | +$180K | 0.1% | 247 |
|
|
2018
Q4 | $2.53M | Sell |
345,637
-35,316
| -9% | -$296K | 0.11% | 246 |
|
|
2018
Q3 | $3.33M | Sell |
380,953
-11,066
| -3% | -$113K | 0.13% | 236 |
|
|
2018
Q2 | $4.41M | Sell |
392,019
-63,856
| -14% | -$761K | 0.18% | 210 |
|
|
2018
Q1 | $5.07M | Buy |
455,875
+17,075
| +4% | +$214K | 0.22% | 173 |
|
|
2017
Q4 | $5.6M | Sell |
438,800
-39,300
| -8% | -$519K | 0.23% | 166 |
|
|
2017
Q3 | $6.8M | Buy |
478,100
+27,875
| +6% | +$349K | 0.27% | 139 |
|
|
2017
Q2 | $5.81M | Buy |
450,225
+33,790
| +8% | +$435K | 0.24% | 148 |
|
|
2017
Q1 | $5.98M | Buy |
416,435
+23,740
| +6% | +$349K | 0.25% | 144 |
|
|
2016
Q4 | $6.13M | Buy |
392,695
+94,750
| +32% | +$1.3M | 0.26% | 137 |
|
|
2016
Q3 | $3.51M | Buy |
297,945
+62,870
| +27% | +$828K | 0.18% | 174 |
|
|
2016
Q2 | $3.27M | Buy |
235,075
+675
| +0.3% | +$8.95K | 0.19% | 180 |
|
|
2016
Q1 | $2.73M | Buy |
234,400
+63,370
| +37% | +$805K | 0.27% | 123 |
|
|
2015
Q4 | $2.8M | Buy |
171,030
+63,480
| +59% | +$1.01M | 0.23% | 134 |
|
|
2015
Q3 | $1.46M | Sell |
107,550
-108,229
| -50% | -$1.47M | 0.13% | 178 |
|
|
2015
Q2 | $2.74M | Buy |
215,779
+36,354
| +20% | +$412K | 0.22% | 127 |
|
|
2015
Q1 | $2.13M | Buy |
179,425
+43,700
| +32% | +$501K | 0.18% | 141 |
|
|
2014
Q4 | $1.69M | Sell |
135,725
-46,710
| -26% | -$477K | 0.14% | 138 |
|
|
2014
Q3 | $1.7M | Sell |
182,435
-25,400
| -12% | -$195K | 0.16% | 123 |
|
|
2014
Q2 | $1.35M | Buy |
207,835
+46,310
| +29% | +$306K | 0.13% | 150 |
|
|
2014
Q1 | $1.3M | Sell |
161,525
-10,400
| -6% | -$102K | 0.12% | 170 |
|
|
2013
Q4 | $1.72M | Buy |
+171,925
| New | +$1.19M | 0.15% | 140 |
|
Other funds holding CCRN
SFM
RA
ACB
Foundry Partners's CCRN Position: Q3 2024 in Review
Foundry Partners sold out of Cross Country Healthcare (CCRN) in Q3 2024, closing a stake of 70,245 shares — an estimated $972K sold.
Foundry Partners first reported a position in CCRN in Q4 2013 and held it in 31 quarters. The position peaked at $7.57M in Q2 2023. 180 funds tracked by Wall St. Rank hold CCRN as of Q3 2024.
- Foundry Partners reported no remaining Cross Country Healthcare position as of Q3 2024 after selling out during the quarter.
- Foundry Partners sold 70,245 Cross Country Healthcare shares in Q3 2024, an estimated $972K.
- Foundry Partners first reported a position in Cross Country Healthcare in Q4 2013 and held it in 31 quarters.
- Foundry Partners's Cross Country Healthcare position peaked at $7.57M in Q2 2023.
- 180 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2024.
Based on Foundry Partners's 13F filing for Q3 2024, filed 8 Nov 2024.